Atlas Trials

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Clinical trial NCT02223052 · COMPLETED

Trial details

NCT number
NCT02223052
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's LymphomaLymphomaMultiple MyelomaAcute Myeloid LeukemiaLeukemiaMyelodysplastic SyndromesNeoplasmsMelanomaBreast CancerMetastatic Breast Cancer
Start date
2014-10-27
Primary completion
2018-06-11
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.